🧠 Ask this record

Get an AI answer drawn only from the NIH Pandemic-Era Grants documents indexed here — every claim cited back to the filing or proceeding it came from. It will tell you plainly when the record doesn't cover your question, rather than guessing.

9873 documents

CD38-TARGETED IMMUNOPET OF MYELOMA: PHASE 2 TRIAL OF CLINICAL APPLICATIONS

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Carl Ola Landgren · HOAG MEMORIAL HOSPITAL PRESBYTERIAN · 2024 · $560,238 — Project Summary / Abstract Multiple myeloma is a plasma cell neoplasm with poor prognosis but promising future treatment. Current measurements of myeloma disease burden are suboptimal, and this limits clinical care. We have completed a first-in-human trial of CD38-targeted immunoPET with the radiola…

Astrocyte regulation of amygdala circuit function

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Junsung Woo · BAYLOR COLLEGE OF MEDICINE · 2024 · $608,297 — Summary Astrocytes are the most abundant type of glial cell in the brain, playing vital roles in all facets of brain physiology. Given their central role in brain function, astrocytes have been implicated in a variety of psychiatric disorders including autism, anxiety, schizophrenia, depression, and…

Assessing Multi-level Barriers to Racial Equity in Living Liver Donor Transplantation

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Elisa J Gordon · VANDERBILT UNIVERSITY MEDICAL CENTER · 2024 · $241,318 — PROJECT SUMMARY/ABSTRACT Due to the organ shortage, more than 15,000 patients with end-stage liver disease (ESLD) are waiting for a life-saving liver transplant (LT) in the US, but fewer than 50% of waitlisted patients will go on to receive a LT.1 As a result, more than 2,000 LT waitlisted patients…

Bay Area Cancer Target Discovery and Development

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Sourav Bandyopadhyay · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2024 · $942,785 — PROJECT SUMMARY Our general strategy is to take advantage of novel tools and methodologies that we have developed during our first two CTD^2 funding periods– more specifically pioneering and applying CRISPR based technologies to aid the discovery and characterization of novel cancer targets and thei…

Mechanisms of Motion Detection in Retinal Neural Network

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Tomomi Ichinose · WAYNE STATE UNIVERSITY · 2024 · $453,021 — Abstract Detection of moving objects is a retinal function which is crucial for an animal's survival. Multiple neurons and neural networks in the retina have been identified as critical players in this task, including starburst amacrine cells (SACs) and direction-selective ganglion cells (DSGCs), wh…

Targeting centrosome‐mitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

William Douglas Cress · PONCE SCHOOL OF MEDICINE · 2024 · $486,917 — Non-Hispanic black (NHB) and Hispanic/Latino (H/L) women in the United States (US) have higher probabilities of breast cancer-related death than non-Hispanic white (NHW) women. H/L women from the Caribbean (C-H/L, Puerto Rican, Cuban and Dominican) and black H/L are at an even higher risk of death t…

Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Irene Cortes-Puch · EICOSIS, LLC · 2024 · $2,141,943 — Summary/Abstract EicOsis is developing a first-in-class analgesic with efficacy against neuropathic pain that will replace and dose spare opioids and thus prevent opioid use disorders (OUDs). The target of the small molecule inhibitor EC5026 is the soluble epoxide hydrolase, a master regulatory enzy…

A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease.

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Paul Michael Arnaboldi · BIOPEPTIDES, INC. · 2024 · $971,664 — Babesia microti is a parasite that is transmitted by the same species of ticks that transmit Lyme disease. It is the causative agent of babesiosis, a disease with a wide array of clinical presentations that can range from an asymptomatic carrier state in some otherwise healthy individuals to causing…

Precision Tumor Sampling of Melanoma Using Laser Microbiopsy

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Sapun H Parekh · UNIVERSITY OF TEXAS AT AUSTIN · 2024 · $203,610 — ABSTRACT Melanoma is the fifth most common cancer in the US with almost 100,000 cases estimated for 2023. Late-stage disease has a five-year survival of just 30%, resulting in almost 8,000 deaths in the US alone. When detected early, melanoma has a survival rate of 99%; however, a widely adopted scr…

Development of a highly sensitive DNA hypermethylation-based kit to identify Barrett's esophagus patients at high risk of progressing to esophageal adenocarcinoma

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Zhongren Zhou · PRE-CANCER DIAGNOSIS, LLC · 2024 · $398,738 — Summary The incidence of esophageal adenocarcinoma (EAC) has increased 600-700% in North America since the 1980s. EAC only has 18-22% of an overall 5-year survival rate because most patients are discovered at an advanced stage. The single major risk factor for the development of EAC is Barrett’s eso…

Protein-RNA interactions in cancer

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Dinesh S. Rao · UNIVERSITY OF CALIFORNIA SANTA CRUZ · 2024 · $580,298 — PROJECT SUMMARY/ ABSTRACT Protein-RNA interactions underlie an important and understudied component of gene regulation. RNA-binding proteins carry out numerous functions relating to the production, splicing, processing, and stability of mRNA molecules. A few years ago, we discovered that the oncofet…

Cortical Mechanisms of Traumatic Stress

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

James P Herman · UNIVERSITY OF CINCINNATI · 2024 · $578,180 — Summary Traumatic stress exposure elicits behavioral and physiological responses that can compromise health and well-being, generating brain and bodily changes that can intrude on appropriate emotional regulation. Numerous disease states, most notably post-traumatic stress disorder, share behavioral…

Police Diversion to Treatment for Opioid Use Disorder: A Mixed Methods Study

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Brandon del Pozo · RHODE ISLAND HOSPITAL · 2024 · $162,397 — Abstract Text This timely and significant K01 award will provide the PI, Dr. del Pozo, with the training and expertise necessary to achieve his long-term goal of becoming a leading investigator of the health outcomes of policing in relation to substance use disorders. Drug overdose deaths have reach…

HAZMAT Training at DOE Nuclear Weapons Complex

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

William Kester Nash · NATIONAL PARTNERSHIP/ENVIRONMNTL/TECH/ED · 2024 · $1,002,953 — The Partnership for Environmental Technology Education (PETE) submits this proposal on behalf of the Community College for Health and Safety Training (CCCHST) serving Department of Energy (DOE) environmental restoration and waste management sites at: Oak Ridge Operations, TN; Portsmouth Site, OH; Sa…

Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Leomar Y Ballester · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2024 · $260,634 — Project Summary/Abstract Primary and metastatic central nervous system tumors (CNS) are associated with a high degree of morbidity and mortality. There is a need for new and more effective strategies for diagnosing, treating and monitoring patients with primary and metastatic CNS tumors. Methodologi…

Roles and regulation of transcriptional reprogramming in squamous carcinogenesis

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Markus Schober · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2024 · $468,096 — SUMMARY Mutations that activate proto-oncogenes or inactivate tumor suppressor genes are the root causes of tumor initiation, but recent genomic analyses also detect these mutations in many cells of healthy tissues. These data and classic skin carcinogenesis studies suggest that mutations in proto-o…

Clinical and Translational Science Collaborative of Northern Ohio, Systems Marketing Analysis for Research Translation (SMART) Innovation Program

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Brian Joseph Biroscak · CASE WESTERN RESERVE UNIVERSITY · 2024 · $804,701 — PROJECT ABSTRACT The Systems Marketing Analysis for Research Translation (SMART) Innovation Program brings a cutting- edge set of tools together to improve clinical and translational research effectiveness, efficiency, and equity and thereby enhance public health and health care delivery. The SMART…

Impacts of phenology on disease transmission dynamics

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Dustin Brisson · UNIVERSITY OF PENNSYLVANIA · 2024 · $580,899 — The proposed projects are a comprehensive effort to rigorously investigate the contribution of phenology - or seasonal activity - to pathogen transmission dynamics using 3 widespread zoonotic pathogens carried by black-legged ticks. Variation in seasonal activity patterns and life-history events, w…

Computational model-driven design to mitigate vein graft failure after coronary artery bypass

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Jay D. Humphrey · STANFORD UNIVERSITY · 2024 · $679,261 — Coronary artery bypass graft (CABG) surgery is the gold standard treatment for patients with diffuse, multi-vessel coronary artery disease, with >350,000 surgeries performed each year in the USA. Due to the limited availability of arterial grafts, saphenous vein grafts (SVG) are used in >95% of pati…

Gut Microbiota and Tacrolimus Trough Variability in Kidney Transplant Recipients

NIH Pandemic-Era Grants · Pandemic Era Grants / 2024

Hyunyoung Jeong · WEILL MEDICAL COLL OF CORNELL UNIV · 2024 · $201,725 — PROJECT SUMMARY Kidney transplantation is a life-saving procedure for patients with end-stage renal disease. Tacrolimus is utilized to prevent rejection of the kidney transplant but has a narrow therapeutic window with subtherapeutic tacrolimus levels associated with acute rejection and supratherape…